The data was revealed as a UK delegation headed by MHRA chief executive Lawrence Tallon attended the J PM Healthcare ...
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...
LyfeSci Research & Innovation, a full-service clinical research organization (CRO), announces the acquisition of Clinically Media, a patient recruitment company specializing in data-driven, inclusive ...